The Challenge of Asymptomatic Bacteriuria and Symptomatic Urinary Tract Infections in Patients with Neurogenic Lower Urinary Tract Dysfunction by Tornic, Jure et al.








The Challenge of Asymptomatic Bacteriuria and Symptomatic Urinary Tract
Infections in Patients with Neurogenic Lower Urinary Tract Dysfunction
Tornic, Jure ; Wöllner, Jens ; Leitner, Lorenz ; Mehnert, Ulrich ; Bachmann, Lucas M ; Kessler,
Thomas M
Abstract: PURPOSE We investigated prevalence of asymptomatic bacteriuria and incidence of symp-
tomatic urinary tract infections (UTI) in patients with neurogenic lower urinary tract dysfunction (NLUTD)
undergoing urodynamics and assessed predictors for symptomatic UTI. PATIENTS AND METHODS A
prospective consecutive series of 317 patients (106 women, 211 men) with NLUTD was evaluated. Of
them, 111 (35%) voided spontaneously, 141 (44%) relied on intermittent self-catheterization and 65 (21%)
on an indwelling catheter. Before urodynamics, urine samples were collected by sterile catheterization for
dipstick testing and urine culture. We assessed the association between patient characteristics and the
occurrence of symptomatic UTIs following urodynamics in patients with asymptomatic bacteriuria and
developed a prediction model based on the most important risk factors. RESULTS Urine cultures before
urodynamics were negative in 123 (39%) and positive in 194 (61%) patients. (32%) and e (18%) were the
most frequent bacteria. Of 194 patients with positive culture, 35 (18%) had at least one symptomatic
UTI. In patients with a history of previous UTIs, the overall estimated probability of a symptomatic UTI
was 45%, irrespective of the underlying neurological disorder. CONCLUSIONS About one out of five pa-
tients with asymptomatic bacteriuria will develop a symptomatic UTI in the follow-up year. This rather
low overall probability precludes routine antibiotic prophylaxis or treatment in patients with NLUTD
having asymptomatic bacteriuria as 4 out of 5 patients would be overtreated. However, in patients with
a history of previous symptomatic UTIs antibiotic prescription might be justified.
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Abstract 
Purpose: We investigated prevalence of asymptomatic bacteriuria and incidence of 
symptomatic urinary tract infections (UTI) in patients with neurogenic lower urinary 
tract dysfunction (NLUTD) undergoing urodynamics and assessed predictors for 
symptomatic UTI. 
Patients and Methods: A prospective consecutive series of 317 patients (106 
women, 211 men) with NLUTD was evaluated. Of them, 111 (35%) voided 
spontaneously, 141 (44%) relied on intermittent self-catheterization and 65 (21%) on 
an indwelling catheter. Before urodynamics, urine samples were collected by sterile 
catheterization for dipstick testing and urine culture. We assessed the association 
between patient characteristics and the occurrence of symptomatic UTIs following 
urodynamics in patients with asymptomatic bacteriuria and developed a prediction 
model based on the most important risk factors.  
Results: Urine cultures before urodynamics were negative in 123 (39%) and positive 
in 194 (61%) patients. Escherichia coli (32%) and Klebsiella pneumoniae (18%) were 
the most frequent bacteria. Of 194 patients with positive culture, 35 (18%) had at 

























Copyright © 201  American Urological Association Education and Research, Inc. Unauthorized reproduction of this article is prohibited.9
3 
 
estimated probability of a symptomatic UTI was 45%, irrespective of the underlying 
neurological disorder. 
Conclusions: About one out of five patients with asymptomatic bacteriuria will 
develop a symptomatic UTI in the follow-up year. This rather low overall probability 
precludes routine antibiotic prophylaxis or treatment in patients with NLUTD having 
asymptomatic bacteriuria as 4 out of 5 patients would be overtreated. However, in 
patients with a history of previous symptomatic UTIs antibiotic prescription might be 
justified. 
Introduction  
Asymptomatic bacteriuria has a high prevalence in patients with neurogenic lower 
urinary tract dysfunction (NLUTD) and is considered to be a major risk factor for the 
development of symptomatic urinary tract infections (UTIs).1-3_ENREF_1 As a 
consequence, affected individuals have an increased risk for upper urinary tract 
damage and potentially life-threatening septicemia.3 Furthermore, recurrent UTIs 
may negatively affect quality of life (QoL) due to aggravation of lower urinary tract 
symptoms (LUTS) and recurrent hospitalizations in the individual.4 
As many patients with NLUTD need to rely on some form of catheterization 
(intermittent and indwelling) for bladder emptying, bacteriuria, leukocyturia, hematuria 
and positive nitrite are common and do usually not require an antibiotic therapy if no 
additional symptoms such as worsened LUTS, spasticity, fever, or pain are 
present._ENREF_45 However, in daily clinical practice, patients without any symptoms 
are regularly treated with antibiotics based on “pathological” urine findings leading to 
increased risk of bacterial resistance and hence hampering appropriate antibiotic 
treatment in the case of a symptomatic UTI.6 Thus, the management of 
asymptomatic bacteriuria and symptomatic UTIs remain a major challenge in neuro-
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We therefore aimed to investigate the prevalence of asymptomatic bacteriuria and 
incidence of symptomatic UTIs in patients with NLUTD undergoing urodynamic 
investigation (UDI) and assessed predictors for symptomatic UTIs. 
Patients and Methods 
Ethics statement: This study was approved by the local ethics committee of the 
University of Zürich (i.e. the Kantonale Ethikkommission Zürich, Switzerland) and it is 
registered with ClinicalTrials.gov (study registration number: NCT01297647). All 
participants gave written informed consent. 
Patients: A consecutive series of 350 patients with NLUTD undergoing UDI were 
prospectively evaluated from June 2010 till December 2012. 33 patients were 
excluded due to incomplete datasets leaving 317 patients for analysis.  
Measurements: Straight before UDI, urine samples were collected by sterile 
catheterization for dipstick testing (Combur® 10-Test, Roche Diagnostics 
International AG, Rotkreuz, Switzerland) and culture. At that time, no patient had 
clinical signs of symptomatic UTI. In addition, no patient received antibiotic treatment 
within 4 weeks before UDI. Patients were followed for 1 year and the rate of 
symptomatic UTI was calculated as the number of symptomatic UTI (defined as 
bacteriuria with concomitant symptoms / signs such as pain, dysuria, fever, new 
onset or worsening of incontinence, increasing spasticity, cloudy and/or malodorous 
urine and need for antibiotic treatment) during the year following the UDI. 
Statistical analysis: The occurrence of symptomatic UTI per patient was counted. 
Student’s t-test with a significance level of p<0.05 was used to compare mean 
differences between patients with asymptomatic bacteriuria prior to UDI who did and 
did not develop symptomatic UTI during follow-up. We bootstrapped a stepwise 
augmentation logistic regression model 10 times using the occurrence of at least one 
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occurrence of symptomatic UTI as independent variables. Variables chosen in at 
least 80% of the final models were selected for the prediction model. Statistical 
analyses were performed using the Stata 14.2. statistical software package. 
(StataCorp. 2015. Stata Statistical Software: Release 14. College Station, TX: 
StataCorp LP.) 
Results 
Characteristics of the 317 patients are shown in Table 1. In the spinal cord injury 
(SCI) subgroup, the mean duration between SCI and the current evaluation was 
17±11 years. 85 patients suffered from complete (American Spinal Injury Association 
(ASIA) Impairment Scale (AIS) A) and 102 from incomplete lesions (AIS B-D). Video-
urodynamic findings are summarized in Table 2. 
Dipstick urine testing before UDI revealed leukocytes in 48% (152/317) and/or nitrite 
positivity in 16% (52/317). Urine culture yielded any bacterial growth in 61% 
(194/317) and bacterial growth ≥105/mL in 42% (134/317) of the specimens. 
Sensitivity and specificity of dipstick urine testing regarding bacterial growth in urine 
culture are shown in Table 3. 
In urine cultures incubated before UDI, more than 20 different bacterial strains were 
identified. Escherichia coli (32%; 62/194) and Klebsiella pneumoniae (18%; 35/194) 
were most frequently detected (Figure). Antibiotic susceptibility testing was 
performed in 154 out of 194 positive urine cultures and showed in 32% (49/154) 
resistance to trimethoprim-sulfamethoxazole (TMP-SMX), in 19% (29/154) resistance 
to nitrofurantoin, in 18% (28/154) resistance to ciprofloxacin, in 18% (27/154) 
resistance to cefuroxime, in 16% (24/154) resistance to amoxicillin/clavulanic acid, 
and in 1% (2/154) resistance to piperacillin/tazobactam. 
Bacterial growth in urine cultures before UDI was found in 42% (47/111) of the 
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intermittent self-catheterization (ISC), and in 91% (59/65) of patients with an 
indwelling catheter. Regarding the latter subgroup, the bladder was on intermittent 
and continuous drainage in 31% (20/65) and 69% (45/65) of patients, respectively. 
The distribution of the bacterial strains in the different groups was similar, i.e. 
Escherichia coli and Klebsiella pneumoniae were the most frequent germs. 
Remarkably, 82% (159/194) had no symptomatic UTI and 18% (35/194) suffered 
from at least one and 5% (10/194) had ≥3 symptomatic UTIs. Febrile UTIs occurred 
in 8% (15/194) and there was no association with the bladder emptying method. 
To prevent recurrence of symptomatic UTIs, 29% (57/194) of the patients with 
asymptomatic bacteriuria proven before UDI were regularly taking L-methionine or 
cranberry. None of the patients included in this calculation was taking an antibiotic 
prophylaxis. Comparing these patients to those without prophylaxis, the mean rate of 
symptomatic UTIs per year was significantly (p<0.001) higher in the L-methionine 
and cranberry group, i.e. 0.8±0.2 per year versus 0.2±0.1 per year. 
The history of previous UTIs (patients reporting at least one UTI prior to UDI) was the 
strongest parameter identified in the bootstrapping analysis. Table 4 shows the 
estimated probabilities along with actual percentages of symptomatic UTIs. Patients 
with a history of previous UTIs had an overall estimated probability of a symptomatic 
UTI of 45%. The probability distribution of the actual UTI frequencies during the 1-





In our prospective study including 317 patients with NLUTD, we found in more than 
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bladder emptying, the prevalence of asymptomatic bacteriuria was 42%, 62% and 
91% in patients voiding spontaneously, performing aseptic ISC or having an 
indwelling catheter, respectively. However, the overall low incidence of symptomatic 
UTIs of less than 1 per year suggests that most of these patients are colonialized 
with bacteria and that only a very small proportion will develop UTIs even after an 
invasive investigation such as urodynamics. In our patient group, the sensitivity of 
dipstick testing was below 75% with a specificity of over 88%. This means that in our 
cohort approximately 1 out of 4 patients having pathological dipstick findings does 
not show any bacterial growth in the urine culture. Observing the UTI rates 
distinguished by bladder emptying method, patients on aseptic ISC had a twice to 
three times higher symptomatic UTI rate during follow-up than patients voiding 
spontaneously and patients with an indwelling catheter. The reason for this 
phenomenon is most likely multifactorial and might be explained by a beneficial effect 
of continuous bladder drainage on symptomatic UTI rate in patients with an 
indwelling catheter but also by suboptimal adherence to the ISC regime as some 
patients might have reduced ISC frequency to a 1-2 times per day basis on their own 
(ultimately leading to UTIs and other negative consequences). Remarkably, the 
history of previous UTI was a strong independent predictor indicating a higher risk for 




Findings in the context of existing evidence 
In patients with NLUTD, the incidence of UTIs ranges from 1-10/year and the 
prevalence from 40-60%, depending on UTI definition, underlying neurological 
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for prevention of UTIs in patients with NLUTD and reported a UTI incidence of 
1.6/year which is slightly above our findings. However, relevant differences in patient 
population, UTI definition and assessments hinders further comparisons.  
In contrast to the low rate of symptomatic UTIs, we identified a high number of 
bacterial growths in these asymptomatic patients. A similar high incidence of 
bacterial growth in samples from patients with NLUTD and relationship to bladder 
emptying method was described by Ronco et al.9_ENREF_13 and Ryu et al.10 revealing 
a positive urine culture in 70% and 75%, respectively. In addition, the mode of 
bladder emptying was associated with the rate of positive urine cultures. Similar to 
our results, patients with a indwelling catheter (transurethral or suprapubic catheter) 
showed a bacterial growth of more than 80%.10 Beside the impaired bladder function, 
the need for assistance for bladder emptying seems to be relevant for bacteriuria in 
these patients. Indeed, bladder emptying method was the primary determinant of 
UTIs in a prospective rehabilitation cohort study.11 
An additional aim of our study was to evaluate the diagnostic criteria of UTIs in 
patients with NLUTD. Beside clinical signs, urinalysis and urine culture are currently 
recommended to diagnose UTIs in neurological patients.2_ENREF_13 However, dipstick 
testing has limited value,2 despite of its wide use and might be more useful to 
exclude than to prove UTI in patients with NLUTD_ENREF_2 what is also underlined by 
the present study. Moreover, our findings are consistent with the results by Hoffman 
et al.12 who observed in a sample of 56 SCI patients a sensitivity of 64% to predict 
significant bacteriuria. In addition, 30% of patients with positive leukocyte esterase 
and positive nitrite on dipstick testing had negative urine cultures.12 Importantly, 
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We found a wide distribution with more than 20 different uropathogens. Chabros et 
al.14 analyzed more than 3200 urine samples of in-patients from a transplant and 
urological ward detecting more than 50 different microorganisms. In agreement with 
our results, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis were the 
most frequently reported bacteria. Although our cohort consists of patients with 
NLUTD without immunosuppressive therapy, the bacteria distribution was similar. 
 
Implications for practice 
Despite a generally agreed definition of UTI in the neuro-urological patient is still 
lacking, there is consensus that signs and symptoms should be considered in 
addition to laboratory findings.15 Ronco et al.9 proposed a combination of clinical 
signs and leukocyturia to diagnose a UTI but could not determine satisfactory 
thresholds for bacterial and white blood cell count._ENREF_13 According to Massa et 
al.16 clinical signs including cloudy and malodorous urine and leukocyturia seem to 
be the most accurate predictors for a symptomatic UTI.  
To minimize the risk for antibiotic resistance, only symptomatic UTI should be treated 
in patients with NLUTD.1, 2 The resistance rate for classic antibiotics (e.g. TMP-SMX, 
amoxicillin-clavulanic acid and ciprofloxacin) was 18-32% in our study. Bosch et al.17 
investigated the antibiotic resistance in outpatients suffering from symptomatic UTIs: 
In patients with complicated UTIs, the results revealed resistance rates of 68%, 65%, 
and 41% for TMP-SMX, amoxicillin and ciprofloxacin, respectively, nitrofurantoin 
showed a sensitivity rate of 73%. In the group with uncomplicated UTI, TMP-SMX 
and amoxicillin were resistant in 54% and 46%, whereas nitrofurantoin and 
ciprofloxacin had the highest sensitivity rate (89%).17 
Prevention of recurrent symptomatic UTIs in the neuro-urological patient remains a 
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were regularly taken by almost 30% of the patients which had significantly more 
symptomatic UTIs compared to the others reflecting the reason for prescribing these 
products. 
In daily clinical practice, individualized concepts should be considered, avoiding 
screening for and treatment of bacteriuria in the absence of symptoms or signs of 
UTI, optimizing lower urinary tract function by proactive neuro-urological 
management and eliminating risk factors such as urinary stones, indwelling catheters 
and anatomical / mechanical obstruction. In the case that an antibiotic treatment is 
really needed, it should be conducted according to the results of the resistance 
testing. Additionally, statistical models, such as the one proposed by us might be 
used to select patients at higher risk assessment allowing the selection of individuals 
who might profit from antibiotic prescription. 
 
Implications for research 
Multi-drug-resistant uro-pathogenic microorganisms are significantly contributing to 
morbidity and mortality in patients with NLUTD causing a massive economic burden 
for every health care system.19 To reduce the prevalence of these strains, 
unnecessary antibiotic therapies must be avoided, also considering prophylactic 
measures and alternative treatments involving “non-antibiotic” agents. As a physical 
action, bladder irrigations using indwelling or intermittent catheterization might be 
offered as described by Birkhäuser et al.20 in a randomized controlled trial reporting 
that daily bladder irrigation applying tap water reduces the rate of antibiotic treatment 
in patients with ileal pouches._ENREF_21 Next generation DNA sequencing may 
improve diagnostic accuracy and enable direct targeting of bacterial biofilms to 
prevent recurrent UTIs by identifying bacteria which are not detectable using current 
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biofilm from such which are not.21 Bacteriophages are an accepted therapy for UTIs 
in several Eastern European countries and may become a valuable treatment option 
also in patients with NLUTD.22-24 Moreover, several other treatment approaches such 
as probiotics,25 homeopathy26 and UroVaxom® (OM Pharma SA, Meyrin, 
Switzerland)27 are promising and warrant further investigations. Finally, treatments 
such as electrical stimulation of the tibial, pudendal and sacral nerves making 
indwelling and intermittent catheterization redundant should be considered and 
closed-loop ontogenetic neuromodulation systems targeting specific neurons to 
control urinary tract function might completely revolutionize the field. 28  
 
Limitations of the study 
Our study has several limitations. First, our department is a highly specialized 
university neuro-urology center. Thus, negative selection bias including more severe 
cases cannot be excluded and under-representation of non-SCI patients might be an 
issue. Second, there are no age and gender matched control groups which would 
allow for assessing different bladder management measures such as aseptic ISC, 
cranberry intake, low-dose antibiotics, etc. Third, subgroups were small for 
regression analysis so that they had to be merged (i.e. patients with complete SCI, 
incomplete SCI and neurological disorders other than SCI) to have a meaningful 
conclusion, so that no further differentiation on etiologies can be made. Last, the 
follow-up in this study is limited to 1 year. Considering that upper urinary tract 
damage generally evolves slowly over many years, longer follow-up would be 
needed to see if optimal management of recurrent UTIs has also a beneficial effect 
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Despite of the high incidence of bacterial growth in our patient group, the yearly 
incidence of symptomatic UTIs during follow-up was low as only one in five patients 
with asymptomatic bacteriuria developed at least one symptomatic UTI. These 
findings confirm that antibiotic treatment of UTIs in patients with NLUTD should only 
be initiated in presence of clinical signs and bacteriuria. 
Additionally, asymptomatic bacteriuria, proven before invasive examinations of the 
lower urinary tract, does not justify a general recommendation for antibiotic 
prophylaxis or treatment. However, history of previous UTIs might be used in 
neurological patients with asymptomatic bacteriuria for symptomatic UTI risk 
assessment allowing the selection of individuals who might benefit from antibiotics. 
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Probability distribution from a prediction model with the actual frequencies of 
symptomatic UTIs in patients with NLUTD and asymptomatic bacteriuria during the 1-
year follow-up.  
 
Figure: 
Illustration of the distribution of the different bacterial strains detected in urine 
cultures before urodynamic investigation. Escherichia coli and Klebsiella pneumoniae 
were the most frequent bacteria. “Others” (35%, 68/194) include all bacterial germs 
(Aerococcus sp., Citrobacter sp., Corynebacterium sp., Enterobacter sp., 
Enterococcus sp., Klebsiella sp., Lactobacillus sp., Morganella sp., Providencia sp., 
Pseudomonas sp., Serratia sp., Staphylococcus sp.) which were proven in less than 
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Table 1 
Patients characteristics 
    










Mean age [years](±SD) 56 ± 16   
Etiology of NLUTD 







Vertebral disc hernia 
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Mean duration of disease [years] 18 ± 12   






















    
 
ISC = Intermittent self-catheterization 
SD  = Standard deviation 
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Table 2 
Video-urodynamic parameters 
    
Maximum cystometric 
capacity [mL] (±SD) 
590 ± 260   
Compliance [mL/cmH2O] (±SD) 71 ± 56   
Neurogenic detrusor 
overactivity (NDO)  
186/317  (59%) 
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Table 3 
Sensitivity and specificity of dipstick urine testing in regard to bacterial growth in urine culture 
 Sensitivity (95% CI) 
 
Specificity (95% CI) 
Leukocyturia 
 
0.71 (0.64-0.77) 0.89 (0.82-0.94) 
Nitrite positive 
 
0.27 (0.21-0.34) 1.00 (0.97-1.00) 
Combined leukocyturia and nitrite positive 
 
0.32 (0.24-0.40) 1.00 (0.77-1.00) 
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Table 4 
Probability distribution from a prediction model with the actual frequencies of 
symptomatic UTIs in patients with NLUTD and asymptomatic bacteriuria during the 1-year 
follow-up. 
Predictors  Previous UTI  Overall 
  no yes  
Neurological disorder other than SCI n 46 20 66 
     Estimated UTI probability 
 
4% 56% 21% 
     Actual UTI frequency during follow-up  2/14 (7%) 12/14 (86%)  
Complete SCI n 43 30 73 
     Estimated UTI probability  10% 47% 25% 
     Actual UTI frequency during follow-up  4/18 (22%) 14/18 (77%)  
Incomplete SCI  n 41 14 55 
     Estimated UTI probability 
 
0% 21% 5% 
     Actual UTI frequency during follow-up  0/3 (0%) 3/3 (100%)  
Overall n 130 64 194 
     Estimated UTI probability  5% 45% 18% 
     Actual UTI frequency during follow-up  6/35 (17%) 29/35 (83%)  
 
NLUTD = Neurogenic lower urinary tract dysfunction 
SCI = Spinal cord injury 
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Figure 
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